| Q64285443 | A model of amygdala function following plastic changes at specific synapses during extinction |
| Q46518412 | Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels. |
| Q50651454 | Behavioral alterations in cystic fibrosis mice are prevented by cannabinoid treatment in infancy. |
| Q47720196 | Bimodal control of fear-coping strategies by CB₁ cannabinoid receptors. |
| Q33664105 | Brain CB₂ Receptors: Implications for Neuropsychiatric Disorders |
| Q48022869 | CB1 receptor signaling regulates social anxiety and memory |
| Q30410131 | Can fear extinction be enhanced? A review of pharmacological and behavioral findings |
| Q92649379 | Cannabidiol and the Remainder of the Plant Extract Modulate the Effects of Δ9-Tetrahydrocannabinol on Fear Memory Reconsolidation |
| Q30459482 | Cannabinoid CB₂ receptor-mediated regulation of impulsive-like behaviour in DBA/2 mice |
| Q28743317 | Cannabinoid exposure during zebra finch sensorimotor vocal learning persistently alters expression of endocannabinoid signaling elements and acute agonist responsiveness |
| Q36243660 | Cannabinoid facilitation of fear extinction memory recall in humans |
| Q34355727 | Cannabinoid modulation of fear extinction brain circuits: a novel target to advance anxiety treatment |
| Q37649879 | Cannabinoid modulation of prefrontal-limbic activation during fear extinction learning and recall in humans |
| Q37984087 | Cannabinoid-1 receptor (CB1R) blockers as medicines: beyond obesity and cardiometabolic disorders to substance abuse/drug addiction with CB1R neutral antagonists |
| Q92236029 | Characterization of cerebral cortical endocannabinoid levels in a rat inguinal surgery model using liquid chromatography-tandem mass spectrometry (LC-MS/MS) |
| Q50561525 | Chronic cannabinoid exposure reduces phencyclidine-induced schizophrenia-like positive symptoms in adult rats. |
| Q41353871 | Computational search for hypotheses concerning the endocannabinoid contribution to the extinction of fear conditioning |
| Q55265291 | Effect of WIN55-212-2 and Consequences of Extinction Training on Conditioned Fear Memory in PTSD Male Rats. |
| Q47826909 | Effects of repeated long-term psychosocial stress and acute cannabinoid exposure on mouse corticostriatal circuitries: Implications for neuropsychiatric disorders. |
| Q37029513 | Effects of the cannabinoid-1 receptor antagonist rimonabant on psychiatric symptoms in overweight people with schizophrenia: a randomized, double-blind, pilot study |
| Q30472672 | Effects of the novel endocannabinoid uptake inhibitor, LY2183240, on fear-potentiated startle and alcohol-seeking behaviors in mice selectively bred for high alcohol preference |
| Q39031134 | Endocannabinoid System: the Direct and Indirect Involvement in the Memory and Learning Processes-a Short Review |
| Q37568668 | Endocannabinoid system and fear conditioning |
| Q29042501 | Endocannabinoid-mediated synaptic plasticity and addiction-related behavior |
| Q36589751 | Failure to extinguish fear and genetic variability in the human cannabinoid receptor 1. |
| Q28254365 | Fear extinction as a model for translational neuroscience: ten years of progress |
| Q40681082 | Genetic deletion of monoacylglycerol lipase leads to impaired cannabinoid receptor CB₁R signaling and anxiety-like behavior. |
| Q30516052 | Genetic dissection of the role of cannabinoid type-1 receptors in the emotional consequences of repeated social stress in mice |
| Q37663920 | Genetic variation in the endocannabinoid system and response to Cognitive Behavior Therapy for child anxiety disorders |
| Q41687427 | Genome-wide expression and response to exposure-based psychological therapy for anxiety disorders. |
| Q57021638 | Impact of FAAH genetic variation on fronto-amygdala function during emotional processing |
| Q36064473 | Increased Contextual Fear Conditioning in iNOS Knockout Mice: Additional Evidence for the Involvement of Nitric Oxide in Stress-Related Disorders and Contribution of the Endocannabinoid System |
| Q44435277 | Microinjection of 2-arachidonoyl glycerol into the rat ventral hippocampus differentially modulates contextually induced fear, depending on a persistent pain state |
| Q37880502 | Neuroanatomical substrates involved in cannabinoid modulation of defensive responses. |
| Q37254797 | Role of Endocannabinoid Signaling in Anxiety and Depression |
| Q36310074 | Study the Effect of Endocannabinoid System on Rat Behavior in Elevated Plus-Maze |
| Q36358395 | The Neuroprotective Effect of Lithium in cannabinoid Dependence is Mediated through Modulation of Cyclic AMP, ERK1/2 and GSK-3β Phosphorylation in Cerebellar Granular Neurons of Rat |
| Q30471032 | The endocannabinoid system in anxiety, fear memory and habituation |
| Q47618301 | The endocannabinoid system in guarding against fear, anxiety and stress |
| Q30455787 | The endocannabinoid system in the rat dorsolateral periaqueductal grey mediates fear-conditioned analgesia and controls fear expression in the presence of nociceptive tone. |
| Q37142237 | The endocannabinoid system: emotion, learning and addiction |
| Q35072848 | The role of cannabinoids in modulating emotional and non-emotional memory processes in the hippocampus |
| Q37965388 | Treatment of fear memories: interactions between extinction and reconsolidation. |
| Q30596478 | Withdrawal from THC during adolescence: sex differences in locomotor activity and anxiety |